Skip navigation
中文
English
DSpace
CRIS
首頁
單位
研究人員
研究成果檢索
分類瀏覽
單位
研究人員
研究成果檢索
學術出版
幫助
登入
中文
English
NTU Scholars
國立臺灣大學
/
醫學院
/
病理學科所
JEN-CHIEH LEE
研究人員網路
瀏覽統計
Email 通知
RSS Feed
簡歷
研究成果
73
計畫
9
研究成果
(全部)
全部
期刊文章
回顧型論文
其他
顯示/隱藏過濾條件
依作者
10
jen-chieh lee
8
jia-huei tsai
5
ching-yao yang
5
yung-ming jeng
4
hsu h.-h.
3
chen c.-c.
3
huang h.-y.
3
wang y.-h.
2
chung y.-c.
2
liang c.-w.
.
下一頁 >
主題
6
[sdgs]sdg3
1
adult; aged; alpha thalassemia mental retardation syndrome x linked gene; article; death domain associated protein 6 gene; dedifferentiated liposarcoma; female; fluorescence in situ hybridization; gene; gene expression; human; human tissue; immunohistochemistry; liposarcoma; major clinical study; male; myxosarcoma; overall survival; phenotype; pleomorphic liposarcoma; priority journal; progression free survival; protein depletion; telomere homeostasis; well differentiated liposarcoma; cell dedifferentiation; disease course; disease free survival; down regulation; enzymology; genetics; kaplan meier method; liposarcoma; middle aged; mortality; pathology; proportional hazards model; risk factor; time factor; treatment outcome; very elderly; atrx protein, human; daxx protein, human; dna helicase; nuclear protein; signal transducing adaptor protein; tumor marker; adaptor proteins, signal transducing; adult; aged; aged, 80 and over; biomarkers, tumor; cell dedifferentiation; disease progression; disease-free survival; dna helicases; down-regulation; female; humans; immunohistochemistry; in situ hybridization, fluorescence; kaplan-meier estimate; liposarcoma; male; middle aged; nuclear proteins; proportional hazards models; risk factors; telomere homeostasis; time factors; treatment outcome
1
alpha thalassemia mental retardation syndrome x linked protein; death domain associated protein; protein; telomerase reverse transcriptase; unclassified drug; atrx protein, human; dna helicase; nuclear protein; telomerase; tert protein, human; tumor marker; adult; aged; article; breast cancer; clinical feature; cystosarcoma phylloides; female; fluorescence in situ hybridization; follow up; gene mutation; hemangioendothelioma; hepatic angiosarcoma; histopathology; human; human tissue; kaposi sarcoma; liver sarcoma; major clinical study; male; malignant peripheral nerve sheath tumor; mitosis rate; nasopharynx carcinoma; phenotype; promoter region; protein expression; survival; telomere homeostasis; undifferentiated carcinoma; uterine cervix carcinoma; vascular tumor; angiosarcoma; down regulation; enzymology; genetics; immunohistochemistry; liver tumor; middle aged; mortality; mutation; nucleotide sequence; pathology; prognosis; skin tumor; telomere; adult; aged; dna helicases; dna mutational analysis; down-regulation; female; hemangioendothelioma, epithelioid; hemangiosarcoma; humans; immunohistochemistry; in situ hybridization, fluorescence; liver neoplasms; male; middle aged; mutation; nuclear proteins; prognosis; promoter regions, genetic; sarcoma, kaposi; skin neoplasms; telomerase; telomere; telomere homeostasis; tumor markers, biological
1
anaplastic lymphoma kinase; anaplastic lymphoma kinase inhibitor; cd30 antigen; cell protein; crizotinib; desmin; hybrid protein; ran binding protein 2; smooth muscle actin; unclassified drug; anaplastic lymphoma kinase; nuclear protein; protein tyrosine kinase; ran-binding protein 1; adolescent; adult; aged; alk gene; anisonucleosis; article; ascites fluid; cancer mortality; cancer radiotherapy; cancer recurrence; cancer surgery; cancer survival; cell nucleus; cell structure; chromatin; chromosome analysis; clinical article; cytopathology; cytoplasm; cytoreductive surgery; diagnostic error; disease course; eosinophil; eosinophil count; epithelioid cell; epithelioid inflammatory myofibroblastic sarcoma; female; fine needle aspiration biopsy; fluorescence in situ hybridization; gene; hepatic encephalopathy; histiocyte; histopathology; human; human cell; human tissue; immunohistochemistry; immunophenotyping; inflammatory cell; intermethod comparison; lymphocytic infiltration; male; mesothelium cell; molecular imprinting; molecularly targeted therapy; multinuclear cell; myxoid stroma; neutrophil; nucleolus; plasma cell; plasma cell granuloma; pleura effusion; priority journal; protein expression; reverse transcription polymerase chain reaction; spindle cell; stroma; tumor cell; tumor localization; tumor necrosis; tumor volume; chromosome analysis; cytodiagnosis; epidemiology; genetics; immunohistochemistry; liver tumor; lung tumor; metabolism; middle aged; myofibroblast; pathology; procedures; real time polymerase chain reaction; register; sarcoma; sensitivity and specificity; adolescent; adult; biopsy, fine-needle; cytodiagnosis; cytogenetic analysis; female; humans; immunohistochemistry; in situ hybridization, fluorescence; liver neoplasms; lung neoplasms; male; middle aged; myofibroblasts; nuclear proteins; real-time polymerase chain reaction; receptor protein-tyrosine kinases; registries; sampling studies; sarcoma; sensitivity and specificity
1
atrx protein, human; dna helicase; nuclear protein; telomerase; tert protein, human; adult; aged; biosynthesis; female; fluorescence in situ hybridization; genetics; human; immunohistochemistry; kaplan meier method; leiomyosarcoma; male; middle aged; mortality; nucleotide sequence; pathology; physiology; retrospective study; telomere; telomere homeostasis; very elderly; adult; aged; aged, 80 and over; dna helicases; dna mutational analysis; female; humans; immunohistochemistry; in situ hybridization, fluorescence; kaplan-meier estimate; leiomyosarcoma; male; middle aged; nuclear proteins; retrospective studies; telomerase; telomere; telomere homeostasis
1
cyclin dependent kinase 4; cyclin dependent kinase inhibitor 2a; protein mdm2; adult; aged; anatomy; article; cancer grading; cancer localization; cellular parameters; clinical article; controlled study; dedifferentiated liposarcoma; differential diagnosis; female; fluorescence in situ hybridization; gene overexpression; histopathology; human; human cell; human tissue; immunohistochemistry; liposarcoma; male; nuclear pleomorphism; priority journal; spindle cell sarcoma; adipose tissue; aged; cell transformation, neoplastic; dna, neoplasm; female; gene amplification; humans; in situ hybridization, fluorescence; liposarcoma; male; middle aged; proto-oncogene proteins c-mdm2; soft tissue neoplasms
1
protein p53; adult; article; bioinformatics; controlled study; dna extraction; female; fluorescence in situ hybridization; frameshift mutation; gene mutation; gene sequence; human; human tissue; immunohistochemistry; leiomyosarcoma; loss of function mutation; major clinical study; male; middle aged; next generation sequencing; polymerase chain reaction; prevalence; protein expression; sequence analysis; signal transduction; tumor differentiation; tumor gene; tumor necrosis
依日期
2
2020 - 2023
8
2010 - 2019
依類型
9
journal article
1
journal article
全文
10
no fulltext
關閉過濾條件
再查詢
作者:
jau-yu liau
第 1 到 10 筆結果,共 10 筆。
公開日期
標題
作者
來源出版物
scopus
WOS
全文
1
2020
GNA11 joins GNAQ and GNA14 as a recurrently mutated gene in anastomosing hemangioma
JAU-YU LIAU
; JIA-HUEI TSAI
; Lan J.; Chen C.-C.; Wang Y.-H.; JEN-CHIEH LEE
; Huang H.-Y.
Virchows Archiv
22
13
2
2020
Thrombotic Hemangioma with Organizing/Anastomosing Features: Expanding the Spectrum of GNA -mutated Hemangiomas with a Predilection for the Skin of the Lower Abdominal Regions
JAU-YU LIAU
; JEN-CHIEH LEE
; JIA-HUEI TSAI
; Chen C.-C.; Wang Y.-H.; Chung Y.-C.
American Journal of Surgical Pathology
4
3
3
2019
High frequency of GNA14, GNAQ, and GNA11 mutations in cherry hemangioma: a histopathological and molecular study of 85 cases indicating GNA14 as the most commonly mutated gene in vascular neoplasms
JAU-YU LIAU
; JEN-CHIEH LEE
; JIA-HUEI TSAI
; Chen C.-C.; Chung Y.-C.; Wang Y.-H.
Modern Pathology
29
25
4
2015
Targeted next-generation sequencing of cancer genes identified frequent TP53 and ATRX mutations in leiomyosarcoma
CHING-YAO YANG
; JAU-YU LIAU
; Huang W.-J.; YU-TING CHANG
; MING-CHU CHANG
; JEN-CHIEH LEE
; JIA-HUEI TSAI
; Su Y.-N.; Hung C.-C.; YUNG-MING JENG
American Journal of Translational Research
43
5
2015
Leiomyosarcoma with alternative lengthening of telomeres is associated with aggressive histologic features, loss of ATRX expression, and poor clinical outcome
JAU-YU LIAU
; JIA-HUEI TSAI
; YUNG-MING JENG
; JEN-CHIEH LEE
; Hsu H.-H.; CHING-YAO YANG
American Journal of Surgical Pathology
71
66
6
2015
Cytopathologic features of epithelioid inflammatory myofibroblastic sarcoma with correlation of histopathology, immunohistochemistry, and molecular cytogenetic analysis
JEN-CHIEH LEE
; Wu J.-M.; JAU-YU LIAU
; Huang H.-Y.; Lo C.-Y.; I-SHIOW JAN
; Hornick J.L.; Qian X.
Cancer Cytopathology
24
15
7
2015
Alternative lengthening of telomeres and loss of ATRX are frequent events in pleomorphic and dedifferentiated liposarcomas
JEN-CHIEH LEE
; YUNG-MING JENG
; JAU-YU LIAU
; JIA-HUEI TSAI
; Hsu H.-H.; CHING-YAO YANG
Modern Pathology
40
39
8
2015
Comprehensive screening of alternative lengthening of telomeres phenotype and loss of ATRX expression in sarcomas
JAU-YU LIAU
; JEN-CHIEH LEE
; JIA-HUEI TSAI
; CHING-YAO YANG
; Liu T.-L.; Ke Z.-L.; Hsu H.-H.; YUNG-MING JENG
Modern Pathology
49
47
9
2015
Alternative lengthening of telomeres phenotype in malignant vascular tumors is highly associated with loss of ATRX expression and is frequently observed in hepatic angiosarcomas
JAU-YU LIAU
; JIA-HUEI TSAI
; CHING-YAO YANG
; JEN-CHIEH LEE
; Liang C.-W.; Hsu H.-H.; YUNG-MING JENG
Human Pathology
42
39
10
2013
Dedifferentiated liposarcoma with homologous lipoblastic differentiation: Expanding the spectrum to include low-grade tumours
JAU-YU LIAU
; JEN-CHIEH LEE
; CHEN-TU WU
; KUAN-TING KUO
; Huang H.-Y.; Liang C.-W.
Histopathology
23
18
申請連結研究人員資料
以 ORCID 登入申請連結此個人資料
ORCID Login
Contact via feedback form
若您要聯絡網站管理員,請點選以下按鈕